Read more
Medical Nanobiotechnology: Nanomedicine for Repair, Regeneration, Remodelling, and Recovery thoroughly reviews the potential of functionalized biomaterials as ideal candidates for nanomedicine. This book covers advances in the development of nanotheranostic agents that can simultaneously help in both effective therapy and rapid diagnosis. A range of materials is covered, including their fabrication, characterization, and assessment, as well as their functionalization and incorporation into implants and medical devices. Clinical aspects and challenges are discussed, helping bridge the gap between laboratory research and the translational impact as nanomedicine begins to develop point-of-care customized therapy. This book is an interdisciplinary reference for researchers and R&D groups interested in the development of novel nanobiomaterials for therapeutic applications.
List of contents
- Biomaterials and bioengineering: A detailed overview
- Nanostructures for diagnosis and biosensing
- Engineered materials for improving various imaging modalities
- Enzyme-functionalized nanodrugs
- Metal and metal oxide-based nanostructures for drug delivery
- Carbon-based and polymeric nanostructures for the delivery of therapeutics: Recent advancements and future prospects
- Targeted delivery strategies for nanomedicine
- Advanced materials for triggered release of drugs
- Nanozyme-associated toxicity and regulation
- Novel materials for 3D and 4D bioprinting of organs and tissues
- Nanomedicine in tissue regeneration
- Nanomedicine and biomaterials for wound healing and repair applications
- Recent advancements in nanobiomaterials for the management of ischemic diseases
- Application of nanobiomaterials in tissue engineering, repair, and cell remodeling
- Immunomodulation strategies of nanobiomaterials by modulating surface chemistry and physical properties
- Developing smart medical implants using functionalized carbon nanostructures
- Graphdiyne-based biomaterials for biosensor and imaging applications
- Surface-functionalized magnetic nanomaterials for the diagnosis and targeted therapy against cancer
- Nanohybrids for the detection and control of infectious diseases
- Polymer-based formulations against metastatic non-small-cell lung cancer: A nanotherapeutic approach
About the author
Dr. Sougata Ghosh is an Associate Professor in the Department of Microbiology at RK University, India, with a B.Sc., M.Sc., and Ph.D. in Microbiology from Savitribai Phule Pune University. He also serves as a Visiting Professor at Kasetsart University in Thailand and Northeastern University in the USA. Ghosh has led a DBT-funded Foldscope Research Project, filed seven patents, edited ten books, and authored 256 publications with 5,258 citations. He has spoken at numerous international conferences and reviews for 79 journals. A life member of the Association of Microbiologists of India, he has been recognized in Stanford's World Top 2% Scientists Ranking. His research focuses on nanobiotechnology, applied microbiology, and bioremediation.Thomas J. Webster is a Professor at the School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, China. He is also a Visiting Professor at the Center for Biomaterials, Vellore Institute of Technology, Vellore, India and the Department of Materials Science and Engineering, Federal University of Piaui, Brazil. His degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S., 1997; Ph.D., 2000). He has served as a professor at Purdue University (2000-2005), Brown University (2005-2012), and Northeastern University (2012-2021). He was the founding editor-in-chief of the International Journal of Nanomedicine (pioneering the open-access format). Prof. Webster has received numerous honors including: 2012, Fellow, American Institute for Medical and Biological Engineering; 2013, Fellow, Biomedical Engineering Society; 2016, International College of Fellows, Biomaterials Science and Engineering; 2016, Acta Biomaterialia Silver Award; 2019, Overseas Fellow, Royal Society of Medicine (UK); and 2022, Clarivate Most Distinguished Researcher (Top 0.1% in citations). He also served as the President of the U.S. Society For Biomaterials.
